Nuformix Plc (GB:NFX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nuformix plc has announced that its directors have participated in a recent fundraising effort, purchasing substantial shares as part of a £300,000 placement. Notably, Non-Executive Chairman Julian Gilbert and Non-Executive Director Maddy Kennedy each acquired 22 million shares, while Executive Director Dan Gooding purchased 12 million shares. This move underscores the company’s focus on drug repurposing in fibrosis and oncology, potentially signaling confidence in its strategic direction.
For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.